WednesdayAug 08, 2018 9:00 am

Specific Therapeutic Benefits of Cannabidiol (CBD) Validated by FDA

HempWire Editorial Coverage: In a landmark announcement, the U.S. Food and Drug Administration (FDA) recently approved a drug derived from pure cannabidiol (CBD), Epidiolex, to treat seizures associated with certain forms of severe epilepsy, setting the stage for huge changes in the world of cannabidiol (CBD). FDA approval of a cannabis-based drug represents seismic political, legal and economic shifts Approval likely will lead to more clinical research and further validation of CBD therapeutic efficacy CBD market projected to explode to more than $2 billion in two years with 39 percent CAGR What’s most transformative about this drug approval is that…

Continue Reading

TuesdayAug 07, 2018 11:32 am

BLOCKStrain Technology Corp. (TSX.V: DNAX) Reaches Key Milestones toward Imminent Launch of Seed-to-Sale Cannabis Tracking Software

Major features finalized under aggressive deadline, with product launch mere weeks away Proprietary technology suite tracks cannabis end-to-end with blockchain-protected solution for growers, breeders Current cannabis testing system vulnerable, leaving consumers and producers exposed to risk Strategic partnership announced to implement BLOCKStrain platform’s benefits into regulatory framework for medical and adult-use cannabis in Canada Canada’s inexorable march toward full legalization of cannabis for the adult user in both the medical and recreational markets is much anticipated by the public and Vancouver, Canada-based BLOCKStrain Technology Corp. (TSX.V: DNAX). Major features of BLOCKStrain’s proprietary, end-to-end cannabis tracking platform are rapidly being finalized by…

Continue Reading

MondayAug 06, 2018 10:04 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) to Launch OKI Brand CBD-Infused Products in 3Q2018, Signs Agreement for Access to 2,400 Stores

PHVAF inks agreement with Acosta’s National Specialty Sales division to sell to 2,400 retailers across U.S., will later have access to 25,000 more supermarkets, such as Wal-Mart and Target Jim Bailey, PHVAF CEO and president, terms crossover distribution into mainstream national retailers a “significant milestone” for the CBD industry; market channel is valued at $4.1 billion OKI line to consist of CBD-infused beverages, such as iced tea and flavored infused waters, plus tinctures and capsules; it will be available to consumers in 3Q2018 Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) will launch its OKI brand of premium CBD products to…

Continue Reading

FridayAug 03, 2018 2:44 pm

Earth Science Tech, Inc. (ETST) Poised to Leverage Full-Spectrum CBD Product Line in Projected $2 Billion Market

Earth Science Tech to add three full-spectrum CBD chocolate offerings to product line Testing to begin on CBD-based patent products Earth Science Tech products will be available to 90,000 retail outlets throughout U.S. On the heels of a major decision by the U.S. Food and Drug Administration (FDA) to approve Epidiolex, a drug derived from pure cannabidiol (CBD), to treat seizures associated with certain forms of severe epilepsy, Earth Science Tech, Inc. (OTC: ETST) is repositioning its line of full-spectrum CBD offerings. Included in this move is the announcement that the company, along with joint venture partner Karmavore Superfoods, will…

Continue Reading

FridayAug 03, 2018 1:58 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enabling Companies to Produce High-Quality Cannabis-Infused Products

80 percent of the company’s total revenue anticipated from the licensing of DehydraTECH™ Nuke Enterprises renewed its license, sending a strong vote of confidence in the technology Enabled GP Holdings to create a high-performing cannabis-infused beverage Biolog Inc. is developing products which will allow processors and consumers to turn almost any food or beverage into a cannabis edible Beginning production of a line of cannabis-infused alcohol-free beverages through a new licensing agreement Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a drug delivery platform innovator, utilizes its unique patented DehydraTECH™ delivery technology to enhance the products of its clients. This patented…

Continue Reading

FridayAug 03, 2018 11:52 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advances Controlled Synthesis of Scorpion Venom Peptides for Brain Therapies

PreveCeutical’s ‘Nature Identical™’ efforts aim to create consistently reproducible versions of found-in-nature therapeutics Company has begun engineering redesign phase of select identified peptides derived from famed scorpion venom Preventative therapeutics market expected to generate $196.9 billion in revenues by 2024, demonstrating alternative health products’ potential PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) efforts to develop a synthesized and consistently reproducible ‘Nature Identical™’ scorpion venom, popular as a pain reliever and cancer therapy, has taken a new step toward marketability as the company commences work on re-engineering venom peptide components to stabilize them. The biotech company based in British…

Continue Reading

ThursdayAug 02, 2018 2:15 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Subsidiary Inks Another Supply Contract for Upcoming Cannabis Crop

Operating in world’s two largest cannabis markets – California and Canada Cannabis concentrate extraction service agreement inked with Cannabis Strategic Venture subsidiary Pure Applied Sciences, Inc. to provide white label services of high quality, ultra-purified cannabis extracts Construction underway in California and Canada of large scale, purpose-built current cGMP designed greenhouses for cannabis cultivation and production Supply agreement with Canopy Growth Corporation to provide up to 90,000 kg of cannabis over two years beginning in early 2019 Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis company headquartered in Vancouver, Canada, is committed to delivering safe, consistent, high-quality products and…

Continue Reading

ThursdayAug 02, 2018 12:11 pm

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is “One to Watch”

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF) Strong balance sheet and capital structure with over CAD $15.5 million cash, no debt, with less than 60 million shares outstanding – fully capitalized for global distribution Expert management team includes former senior executives from Red Bull, Proctor & Gamble, Labatt’s, Stoli Group and the former CEO of Seagram’s International Joint venture with top Canadian licensed producer WeedMD (TSX: WMD) for one of the first federally legal cannabis beverage manufacturing facility, new global distribution partners Developing best-in-class premium CBD-hemp oil…

Continue Reading

ThursdayAug 02, 2018 9:00 am

$1 Trillion Global Health and Wellness Sector Presents Growing Opportunities for Cannabidiol Companies

HempWire Editorial Coverage: Cannabidiol (CBD) products are reaching into the mainstream through a growing health and wellness sector, and savvy companies are looking to position themselves to make the most of this momentum. The health and wellness market grown to over $1 trillion globally as of 2017 Positive shifting regulations globally is opening major international markets to CBD products, especially CBD infused food, beverages and natural health products Larger fortune 500 level food and beverage companies are beginning to consolidate this major growth market via major investments and mergers and acquisitions. In a groundbreaking move, Phivida Holdings, Inc. (CSE: VIDA)…

Continue Reading

WednesdayAug 01, 2018 1:40 pm

Medical Cannabis Payment Solutions (REFG) Names Haridopolos of Florida to Advisory Board, Eyes Expansion in MMJ Space

Mike Haridopolos joins Bruce Starr, Gary Johnson and Curt Bramble on REFG’s advisory board, all from states where medical marijuana is legal – Florida, Oregon, Utah and New Mexico Jeremy Roberts, CEO of REFG, says that naming Haridopolos is an asset to the company, helping to expand its footprint and achieve its corporate objectives REFG, a payment processor and industrial hemp grower with plans to operate a mobile hemp CBD extraction lab, is increasing its role in the legalized cannabis industry Medical Cannabis Payment Solutions (OTC: REFG) is intensifying its focus on cannabis by adding to its advisory board another…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000